InsidersTradesSigma
Follow the 翔宇医疗 share price and the full insider trade history of the company, a publicly traded company based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 翔宇医疗 has published 8 reports. Market capitalisation: €6.6bn. The latest transaction was filed on 1 June 2022 (Purchase). Among the most active insiders: 何永正. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
8 of 8 declarations
翔宇医疗 is a company specializing in the healthcare and pharmaceutical sector, listed on the XSHG market. It focuses on the development and manufacturing of innovative medical products.